Blazar BR - Search Results

1

CRISPR/Cas9-Based Lateral Flow and Fluorescence Diagnostics.

Osborn MJ, Bhardwaj A, Bingea SP, Knipping F, Feser CJ, Lees CJ, Collins DP, Steer CJ, Blazar BR, Tolar J. Osborn MJ, et al. Among authors: blazar br. Bioengineering (Basel). 2021 Feb 12;8(2):23. doi: 10.3390/bioengineering8020023. Bioengineering (Basel). 2021. PMID: 33673107 Free PMC article.

2

Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.

Blazar BR, Lees CJ, Martin PJ, Noelle RJ, Kwon B, Murphy W, Taylor PA. Blazar BR, et al. J Immunol. 2000 Nov 1;165(9):4901-9. doi: 10.4049/jimmunol.165.9.4901. J Immunol. 2000. PMID: 11046015

3

Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions.

Taylor PA, Lees CJ, Waldmann H, Noelle RJ, Blazar BR. Taylor PA, et al. Among authors: blazar br. Blood. 2001 Jul 15;98(2):467-74. doi: 10.1182/blood.v98.2.467. Blood. 2001. PMID: 11435318 Free article.

4

Allogenic fetal liver cells have a distinct competitive engraftment advantage over adult bone marrow cells when infused into fetal as compared with adult severe combined immunodeficient recipients.

Taylor PA, McElmurry RT, Lees CJ, Harrison DE, Blazar BR. Taylor PA, et al. Among authors: blazar br. Blood. 2002 Mar 1;99(5):1870-2. doi: 10.1182/blood.v99.5.1870. Blood. 2002. PMID: 11861310 Free article.

5

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.

Taylor PA, Lees CJ, Blazar BR. Taylor PA, et al. Among authors: blazar br. Blood. 2002 May 15;99(10):3493-9. doi: 10.1182/blood.v99.10.3493. Blood. 2002. PMID: 11986199 Free article.

6

Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions.

Taylor PA, Lees CJ, Wilson JM, Ehrhardt MJ, Campbell MT, Noelle RJ, Blazar BR. Taylor PA, et al. Among authors: blazar br. Blood. 2002 Nov 1;100(9):3400-7. doi: 10.1182/blood-2002-03-0872. Blood. 2002. PMID: 12384443 Free article.

7

Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.

Blazar BR, Sharpe AH, Chen AI, Panoskaltsis-Mortari A, Lees C, Akiba H, Yagita H, Killeen N, Taylor PA. Blazar BR, et al. Blood. 2003 May 1;101(9):3741-8. doi: 10.1182/blood-2002-10-3048. Epub 2003 Jan 9. Blood. 2003. PMID: 12521997 Free article.

8

B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections].

Taylor PA, Lees CJ, Fournier S, Allison JP, Sharpe AH, Blazar BR. Taylor PA, et al. Among authors: blazar br. J Immunol. 2004 Jan 1;172(1):34-9. doi: 10.4049/jimmunol.172.1.34. J Immunol. 2004. PMID: 14688306

9

Real-time in vivo imaging of stem cells following transgenesis by transposition.

Tolar J, Osborn M, Bell S, McElmurry R, Xia L, Riddle M, Panoskaltsis-Mortari A, Jiang Y, McIvor RS, Contag CH, Yant SR, Kay MA, Verfaillie CM, Blazar BR. Tolar J, et al. Among authors: blazar br. Mol Ther. 2005 Jul;12(1):42-8. doi: 10.1016/j.ymthe.2005.02.023. Mol Ther. 2005. PMID: 15963919 Free article.

10

A picornaviral 2A-like sequence-based tricistronic vector allowing for high-level therapeutic gene expression coupled to a dual-reporter system.

Osborn MJ, Panoskaltsis-Mortari A, McElmurry RT, Bell SK, Vignali DA, Ryan MD, Wilber AC, McIvor RS, Tolar J, Blazar BR. Osborn MJ, et al. Among authors: blazar br. Mol Ther. 2005 Sep;12(3):569-74. doi: 10.1016/j.ymthe.2005.04.013. Mol Ther. 2005. PMID: 15964244 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

888 results

Search Page